Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer and Sanofi-Aventis looking to market Exubera
Exubera, a dry powder form of insulin that is inhaled into the lungs prior to eating, using a specially designed inhalation device, has been studied in more than
Exubera, a dry powder form of insulin that is inhaled into the lungs prior to eating, using a specially designed inhalation device, has been studied in more than
The contracts relate to a series of clinical trials that form part of a global phase II and phase III program investigating the safety and efficacy of an
The patients were treated with an iodine-131 radiolabeled tumor necrosis therapy antibody (131I-TNT). Results showed that approximately 90% of patients treated with 131I-TNT had stable disease or better,
The trial, named NOVA, will evaluate the effects of Biobypass on exercise tolerance, heart function, symptoms and quality of life in approximately 129 patients suffering from moderate to
The trial is designed to evaluate the efficacy of PTK/ZK (PTK787/ZK 222584) as a second-line monotherapy in patients with stage IIIb/IV non-small cell lung cancer (NSCLC). The trial,
The company will conduct research and commercially develop products that utilize telomerase activator drugs to restore the regenerative and functional capacity of cells in various organ systems that
The new Manchester Cancer Research Centre (MCRC) will integrate the cancer research efforts of The University of Manchester, the Christie Hospital, the Paterson Institute for Cancer Research and
Reducol is now approved for marketing in food groups including margarine, fermented milk type products, soy drinks, low-fat cheese type products, yoghurt type products, spicy sauces, and salad
The timing of the license renewal for the company’s Liverpool, UK manufacturing facility has come as a sign of relief to many in the company as it means
Patients with co-existing diabetes and hypertension face a major increase in risk of cardiovascular complications, including heart attacks, stroke, heart failure and renal failure. MC-4232 is a novel